早期整合安宁疗护与标准心脏照护在心力衰竭患者中的对比:EPCHF多中心随机对照试验
EPCHF是一项在德国两家大学医院开展的多中心、平行、双臂、开放标签随机对照试验,纳入205例非终末期心力衰竭患者(NYHA II级及以上且NT-proBNP≥400 pg/mL),比较早期整合安宁疗护联合标准心脏照护与单纯标准心脏照护的效果。结果显示,12个月内两组在健康状态(FACIT-PAL)和情绪(KCCQ-OSS)方面均显著改善,但组间无显著差异;全因死亡、心衰相关住院及不良事件方面亦无显著差异。
要点
- 在非终末期心衰患者中,早期整合安宁疗护联合标准心脏照护在改善健康状态和情绪方面不优于单纯标准心脏照护。
- 两组全因死亡、心衰相关住院及不良事件发生率均无显著差异。
- 未来临床实践应考虑根据患者个体需求决定是否引入早期整合安宁疗护。
核心结论
- 在非终末期心力衰竭患者中,标准心脏照护(包括指南导向的药物治疗优化和每3个月定期随访)在改善健康状态和情绪方面与联合早期整合安宁疗护同样有效。
- 未来临床实践应考虑基于患者个体需求来提供早期整合安宁疗护。
研究设计与样本
- EPCHF为多中心、平行、双臂、开放标签、随机对照试验,在德国波恩大学医院和杜塞尔多夫大学医院开展。
- 纳入标准为年龄18岁及以上、心力衰竭、纽约心脏协会(NYHA)心功能分级II级或以上、NT-proBNP浓度大于或等于400 pg/mL。
- 共筛查843例患者,纳入205例,按1:1随机分配至早期整合安宁疗护联合标准心脏照护组(100例)或单纯标准心脏照护组(105例)。
- 随机化采用计算机生成、分配隐藏、可变区组大小,并按研究站点分层。
- 主要终点为健康状态和情绪,每3个月测量一次,持续12个月,使用FACIT-PAL和KCCQ评估,按意向性治疗分析。
关键数值与推荐
- 纳入标准:年龄18岁或以上,心力衰竭,NYHA分级II级或以上,NT-proBNP≥400 pg/mL。
- 主要终点测量工具:FACIT-PAL用于健康状态,KCCQ用于情绪/健康状况,每3个月评估一次,持续12个月。
- 随机分配比例1:1,按研究站点分层,采用计算机生成随机化和分配隐藏。
临床怎么用
- 对于非终末期心力衰竭患者,标准心脏照护(包括指南导向药物治疗优化和定期随访)已能有效改善健康状态和情绪。
- 早期整合安宁疗护应根据患者个体需求考虑,而非普遍常规提供。
- 临床决策时可参考本试验结果,与患者及家属共同讨论安宁疗护的引入时机。
局限性
- 本试验为开放标签设计,可能存在实施偏倚。
- 样本量有限(共205例),可能影响对较小差异的检测效能。
- 研究仅在德国两家大学医院进行,结果外推需谨慎。
- 随访时间为12个月,长期效果未知。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Heart failure is a substantial global health concern that severely affects patients' quality of life. We aimed to compare the effects of early integration of palliative care (EIPC) and standard cardiac care on health status and mood of patients with non-terminal heart failure. METHODS: EPCHF was a multicentre, parallel, two-arm, open-label, randomised controlled trial carried out at University Hospital Bonn and University Hospital Düsseldorf in Germany. Eligible patients (aged 18 years or older) had heart failure, with New York Heart Association class II or more and NT-proBNP concentrations greater than or equal to 400 pg/mL. Patients were randomly assigned (1:1) to receive EIPC with standard cardiac care or standard cardiac care alone. Randomisation was computer-generated with allocation concealment, variable block sizes, and stratification by investigational site. The primary endpoints were health status and mood, measured every 3 months over 12 months using the Functional Assessment of Chronic Illness Therapy-Palliative Care (FACIT-PAL) and the Kansas City Cardiomyopathy Questionnaire (KCCQ), analysed by intention to treat. This trial is registered with DRKS.de, DRKS00013922. FINDINGS: Between May 21, 2019, and Nov 15, 2021, 843 patients were assessed for eligibility, 205 of whom were enrolled (100 assigned to EIPC and 105 assigned to standard cardiac care). 143 (70%) patients were male and 62 (30%) were female. Over 12 months, both groups significantly improved in FACIT-PAL and KCCQ Overall Summary Score (OSS) with no significant differences between the groups (FACIT-PAL adjusted mean difference 0·98 points [95% CI -1·28 to 3·23]; p=0·40; KCCQ-OSS adjusted mean difference -2·06 points [-7·89 to 3·78]; p=0·49). Nine (9%) patients in the EIPC group and seven (7%) patients in the standard cardiac care group died from any cause, with no significant differences in time to death between the two groups (hazard ratio [HR] 1·32 [95% CI 0·49 to 3·54]; p=0·58). 22 (22%) patients in the EIPC group and 21 (21%) patients in the standard cardiac care group were hospitalised at least once due to heart failure, with no significant differences in time to heart-failure-related hospitalisation between the two groups (HR 1·09 [0·61 to 1·98]; p=0·77). 70 (70%) patients in the EIPC group and 62 (59%) in the standard cardiac care group had any adverse events (p=0·10). INTERPRETATION: In this open-label, randomised clinical trial, standard cardiac care, featuring guideline-directed optimisation of medical therapy and regular 3-monthly follow-ups was found to be as effective as when combined with EIPC in improving health status and mood in patients with non-terminal heart failure. Future clinical practices should consider EIPC based on individual patient needs. FUNDING: Federal Ministry of Education and Research.
引用
- Balata M, Radbruch L, Hesse M, et al. Early integration of palliative care versus standard cardiac care for patients with heart failure (EPCHF): a multicentre, parallel, two-arm, open-label, randomised controlled trial. Lancet Healthy Longev. 2024. PMID: 39366392. doi:10.1016/j.lanhl.2024.08.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。